Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP922003.RATlOQmkCPEwf2EJT_w5MoHtiueUqvuj85FYW4YprKfmo130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP922003.RATlOQmkCPEwf2EJT_w5MoHtiueUqvuj85FYW4YprKfmo130_assertion type Assertion NP922003.RATlOQmkCPEwf2EJT_w5MoHtiueUqvuj85FYW4YprKfmo130_head.
- NP922003.RATlOQmkCPEwf2EJT_w5MoHtiueUqvuj85FYW4YprKfmo130_assertion description "[In addition, we found that either deregulated expression of the endogenous PP2A inhibitors SET or CIP2A, overexpression of SETBP1, or downregulation of some PP2A subunits, might be contributing to PP2A inhibition in AML.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP922003.RATlOQmkCPEwf2EJT_w5MoHtiueUqvuj85FYW4YprKfmo130_provenance.
- NP922003.RATlOQmkCPEwf2EJT_w5MoHtiueUqvuj85FYW4YprKfmo130_assertion evidence source_evidence_literature NP922003.RATlOQmkCPEwf2EJT_w5MoHtiueUqvuj85FYW4YprKfmo130_provenance.
- NP922003.RATlOQmkCPEwf2EJT_w5MoHtiueUqvuj85FYW4YprKfmo130_assertion SIO_000772 21233840 NP922003.RATlOQmkCPEwf2EJT_w5MoHtiueUqvuj85FYW4YprKfmo130_provenance.
- NP922003.RATlOQmkCPEwf2EJT_w5MoHtiueUqvuj85FYW4YprKfmo130_assertion wasDerivedFrom befree-20140225 NP922003.RATlOQmkCPEwf2EJT_w5MoHtiueUqvuj85FYW4YprKfmo130_provenance.
- NP922003.RATlOQmkCPEwf2EJT_w5MoHtiueUqvuj85FYW4YprKfmo130_assertion wasGeneratedBy ECO_0000203 NP922003.RATlOQmkCPEwf2EJT_w5MoHtiueUqvuj85FYW4YprKfmo130_provenance.